Clinical Research Directory
Browse clinical research sites, groups, and studies.
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
Sponsor: Ottawa Heart Institute Research Corporation
Summary
A multicentre, parallel group, two arm, single-blinded randomized clinical trial, assessing the efficacy of a patient-tailored catheter ablation (CA) strategy guided by atrial scar mapping in addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).
Official title: Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
502
Start Date
2018-08-24
Completion Date
2024-12
Last Updated
2024-05-08
Healthy Volunteers
No
Conditions
Interventions
Catheter ablation
Wide area circumferential catheter ablation for pulmonary vein isolation of persistent atrial fibrillation
Locations (15)
Libin Cardiovascular Institute
Calgary, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
QEII Health Sciences Centre, Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Hamilton General Hospital
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Southlake Regional Health Centre
Newmarket, Ontario, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Rouge Valley Regional Heart Centre
Toronto, Ontario, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, Canada
Sacre-Coeur Hospital
Montreal, Quebec, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Montreal Heart Institute
Montreal, Quebec, Canada
Institute Universitaire de Cardiologie et Pneumologie du Quebec (IUCPQ)
Québec, Quebec, Canada
CIUSSS de L'Estrie-CHUS-Hopital Fleurimont
Sherbrooke, Quebec, Canada